Molecular Imaging

AI detects Alzheimer’s on brain perfusion SPECT scans

By Will Morton

The model aims to enhance the consistency and confidence of SPECT interpretation supporting current workflows.

February 3, 2026

PSMA-PET predicts patient responses to Ac-225-based RPT

By Will Morton

The finding is an important step for further development of new treatment for advanced metastatic prostate cancer.

January 30, 2026

BAMF Health and Henry Ford Health form theranostics joint venture

By AuntMinnie.com staff writers

BAMF Health's first comprehensive theranostics center opened in 2022 as a model for integrated precision medicine.

January 30, 2026

Nucs AI establishes medical advisory board

By AuntMinnie.com staff writers

Nucs AI has formed its medical advisory board to ensure the company's AI theranostics tech is aligned with clinical practice.

January 29, 2026

ASNC recommends cardiac PET for all CAD patients

By AuntMinnie.com staff writers

The statement is meant to encourage the adoption of cardiac PET to evaluate patients with suspected coronary artery disease (CAD).

January 29, 2026

Siemens Healthineers gets FDA nod for Biograph One PET/MR scanner

By AuntMinnie.com staff writers

Siemens Healthineers has received U.S. FDA clearance for the company's second-generation PET/MR imaging scanner.

January 29, 2026

GEHC gains FDA clearance for MIM LesionID Pro

By AuntMinnie.com staff writers

GEHC has received the U.S. FDA nod for a system that analyzes whole-body tumor burden for PSMA PET/CT and SPECT/CT studies.

January 29, 2026

Alzheimer’s brain pathology differs based on sex

By Will Morton

Understanding gender and sex differences is crucial to identifying effective and equitable prevention and treatment.

January 27, 2026

How does F-18 flurpiridaz PET perform in routine clinical practice?

By Will Morton

A study provides real-world insights into the clinical implementation of F-18 flurpiridaz PET in a diverse group.

January 26, 2026

New study seeks to tailor RLT to individual patients

By Will Morton

A new clinical trial aims to determine how doctors can optimize targeted radioligand therapy (RLT) for men with prostate cancer.

January 26, 2026

Georgia ProtonCare Center enters asset purchase agreement with Emory

By AuntMinnie.com staff writers

Georgia ProtonCare Center has entered into an asset purchase agreement with Emory University.

January 22, 2026

Novel radiopharmaceutical therapy could help treat pleural metastases

By Will Morton

Previously, patients had been heavily treated with standard therapies, such as chemotherapy, immunotherapy, and radiation therapy.

January 22, 2026

Page 1 of 620

Next Page